 |
| september
3, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
- Agilent: MMR IHC Panel pharmDx (Dako Omnis)
Receives European IVDR Certification as a
Companion Diagnostic Test for Colorectal
Cancer More
- Amyris: Dr. Sunil Chandran Rejoins as
Chief Technology Officer to Meet Growing
Customer Demand for Innovative and Renewable
Biological Chemistry More
- CareDx: Issues Comment Letter on Draft LCD
Policy More
- Cartography: Names Dirk Nagorsen, M.D.,
as Chief Medical Officer in Expansion of Its
Clinical Team More
- Charles River: Enhances Cell Therapy
Flex Platform Through Collaboration With
Akadeum Life Sciences More
- Evolv: Launches With First-Ever Oral
Biomimetic Supplement to Deliver GLP-1
Naturally More
- Glycomine: Initiates Dosing in a Global,
Randomized, Placebo-Controlled Phase 2b Study
of GLM101 for the Treatment of PMM2-CDG More
- IDEAYA Biosciences: IND Submission for
IDE892, a Potential Best-In-Class PRMT5
Inhibitor for MTAP-Deletion Solid Tumors More
- IMVARIA: Awarded Phase I NIH SBIR Grant to
Extend the Company’s AI-powered Adjunctive
Diagnostic Service Into Oncology More
- Lyell Immunopharma: Initiation of a Phase 3
Head-to-Head CAR T-Cell Therapy Clinical Trial
in Aggressive Large B-Cell Lymphoma and
Formation of Expert Steering Committee More
- Medable: Launches the Industry’s First
Agentic AI Platform and CRA Agent; Removes
Bottlenecks in Clinical Development More
- PacBio and EpiCypher: Partner to Deliver
Novel Insights Into Epigenomics With Fiber-seq
Workflow More
- Vaxart: Retirement of Chairman Michael J.
Finney, Ph.D. From the Board of Directors More
- Vaxcyte:
Advances VAX-31 Infant Phase 2 Dose-Finding
Study With First Participants Receiving VAX-31
Optimized Dose More
|
|
 |
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Galvanize Therapeutics: Raises $100
Million in Oversubscribed Series C Financing
to Transform the Treatment of Cancer and
Chronic Lung Disease More
- Get Discounted Access to Exclusive
Biotech Intelligence from BYTE51 More
- More on Servier Shelling Out $210M Upfront
to License Ideaya’s Potential First-in-Class
PKC Inhibitor Outside the US More
- Roche’s Genentech Pens $420M Deal for
Omass’ Preclinical IBD Program More
More
More
More*
- The Big4Bio Podcast: Surviving and
Thriving in the Long Biotech Winter Podcast
|
|
 |
 |
| San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
|
Learn More
→ |
|
|
- BiotechTV: N-Power Medicine Launched What It
Is Calling the ‘Industry’s First Prospective
External Control Arm Platform’ for Cancer
Trials – Mark Lee, CEO and a Medical
Oncologist, Explains Why and How It Works Video
- Buck Institute: The Gut Immune System is
Altered in Mouse Model of Alzheimer’s,
Providing a New Target for Therapeutics More
- Cytokinetics Says Heart Drug Data Should
‘Turn Heads’ on Standard of Care More*
More*
More
- Gladstone: Virologist Viewpoints - The
Promise of Cancer Vaccines More
- Mendelspod: Reinventing PCR - Pranav Patel,
N6 Tec Podcast
- New Acting CDC Director Is a Former Silicon
Valley Biotech Investor Who Sparks ‘Intense
Debate’ in Business, Policy Circles More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- ‘We’re Ready To Run’: New Amyris CEO Points
Pioneering Biotech Toward Life After
Bankruptcy More*
|
|
 |
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- 8 Companies Hiring in San Francisco More
- FEATURE: The Power of Peer Learning:
Why Even Top Biotech Leaders Need Mentorship
More
- ICYMI: The Changing Landscape of Diagnostics
More
- ICYMI: CEO's Perspective: The Power of
Pivoting More
- ICYMI: What Defines Great Leadership? More
- Longtime Novo Nordisk Exec Cites ‘Recent
Shifts’ for His Departure; Rocket Pharma CFO
to Resign More*
- Organizational Leader and Business
Strategist Kyle Kinzie Named President &
Partner More
|
|
 |
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Grant Engine Webinar - Mastering Funding in
2025 Sept
3
- Hub and Specialty Pharmacy Models West
(Promo Code 25B4B10 to save 10%) Sept
4-5
- PCC West Pharmaceutical Compliance Congress
Sept
4-5
- Happy Hour Drinks and Bowling With
ACROBiosystems Sept
5
- Charles River Biotech Symposium Sept
8-10
- LinkedIn Strategies for Scientists -
Chaperone Webinar Sept
9
- Philly Builds Bio+ 4th Annual Symposium for
Life Science Innovation and Development Sept
9
- AI Meets Amplification: Smarter PR
Strategies for Life Sciences Companies Sept
10
- International Life Sciences & Biotech
Conference (Discount Code BIG4BIO for 20% Off)
Sept
10–11
- CRAACO: Clinical Research as a Care
Option Sept
15
- Partnerships with Sites Sept
15
- LSX World Congress USA Sept
16-17
- 15th Annual DPHARM Sept
16-17
- Venture Catalyst - Exploring Life Sciences
VC in Los Angeles Sept
16
- RESI Boston 2025 Sept
17
- Discovery On Target Sept
22-25
- Life Sciences Future Sept
25-26
- Science to Strategy: Advanced Degrees in
Consulting Sept
25
- AI LA Life Summit 2025 (Exclusive Discount:
B1G4BAIO) Sept
27
- The MedTech Conference Oct
5-8
- Fierce Biotech Week Oct
7-9
- MedFuel/One Life Science/WOMEN IN BIO
(Discount Code: Big4Bio) Oct
9
- BioFuture Oct
13-14
- 2025 Battle of the Bio\Tech Bands West Oct
21
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
